Companies: 10,638     total market cap: โ‚น12170.341 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alkermes
ALKS
#3093
Rank
โ‚น437.88 B
Marketcap
๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Country
โ‚น2,652
Share price
0.75%
Change (1 day)
-0.44%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for Alkermes (ALKS)

Revenue in 2025 (TTM): โ‚น131.58 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is โ‚น136.67 Billion. In 2024 the company made a revenue of โ‚น133.62 Billion a decrease over the revenue in the year 2023 that were of โ‚น138.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น131.58 B-1.52%
2024 โ‚น133.62 B-3.5%
2023 โ‚น138.47 B50.52%
2022 โ‚น92.00 B5.31%
2021 โ‚น87.36 B15%
2020 โ‚น75.96 B-9.02%
2019 โ‚น83.50 B9.13%
2018 โ‚น76.51 B32.65%
2017 โ‚น57.68 B13.83%
2016 โ‚น50.67 B21.36%
2015 โ‚น41.75 B6.47%
2014 โ‚น39.21 B
2012 โ‚น29.70 B80.79%
2011 โ‚น16.43 B110.79%
2010 โ‚น7.79 B-8.53%
2009 โ‚น8.52 B-48.66%
2008 โ‚น16.60 B73.96%
2007 โ‚น9.54 B-5.82%
2006 โ‚น10.13 B65.59%
2005 โ‚น6.11 B104.25%
2004 โ‚น2.99 B86.5%
2003 โ‚น1.60 B-29.59%
2002 โ‚น2.28 B-7.91%
2001 โ‚น2.47 B19.2%
2000 โ‚น2.07 B92.18%
1999 โ‚น1.08 B-44.92%
1998 โ‚น1.96 B78.51%
1997 โ‚น1.09 B67.13%
1996 โ‚น0.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
โ‚น10.39 B-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 3,057.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 5,957.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 4,027.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.221 T 3,720.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T 1,002.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
โ‚น7.33 B-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.269 T 3,023.90%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
โ‚น5.064 T 3,605.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com